Skip to content

Rapport Therapeutics Inc

RAPP

Latest QuantConomy context for RAPP: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

Rapport Therapeutics Inc

QuantConomy has a structured record for RAPP. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
RAPP
Name
Rapport Therapeutics Inc
Coverage
3 market/data records
Sources
alphavantage alpaca fmp sec nasdaq
Latest signal rows

Recent signals for RAPP

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
executive trade
bearish
37
Jul 1, 08:09 PM Ceesay Abraham (Chief Executive Officer, Director) sold RAPP shares ($0.29M) - 7,344 shares - [weak bearish signal]
earnings release
neutral
40
Mar 10, 12:00 AM RAPP filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-03-10. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
uptrend
very bullish
100
Jun 15, 02:09 PM RAPP uptrend (gain): price 26.85% (strength 100, current 38.245)

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.

Market coverage

Market Exchange Source Asset record
RAPP NASDAQ alphavantage Rapport Therapeutics Inc
RAPP NASDAQ alpaca Rapport Therapeutics, Inc. Common Stock
RAPP NASDAQ fmp Rapport Therapeutics, Inc. Common Stock

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
7
Rows
20
Date Insider Role Type Shares Price Value Filing
Jun 30, 2026 Gault Cheryl Chief Operating Officer sale 1,900 $40.09 $76,174 4 on EDGAR
Jun 29, 2026 Ceesay Abraham Chief Executive Officer sale 7,344 $39.77 $292,062 4 on EDGAR
Jun 10, 2026 Young Wendy B. Director grant 15,200 4 on EDGAR
Jun 10, 2026 Sanchez Ramiro Director grant 15,200 4 on EDGAR
Jun 10, 2026 MARAGANORE JOHN Director grant 15,200 4 on EDGAR
Jun 10, 2026 HEALY JAMES Director grant 15,200 4 on EDGAR
Jun 10, 2026 PEREZ ROBERT J Director grant 15,200 4 on EDGAR
Jun 10, 2026 Silva Paul M Director grant 15,200 4 on EDGAR
May 26, 2026 Third Rock Ventures V, L.P. 10% owner sale 18,572 $40.05 $743,753 4 on EDGAR
May 11, 2026 Third Rock Ventures V, L.P. 10% owner sale 133,618 $40.24 $5,377,323 4 on EDGAR
May 7, 2026 Third Rock Ventures V, L.P. 10% owner sale 271,495 $40.12 $10,892,651 4 on EDGAR
Apr 17, 2026 Yeleswaram Krishnaswamy Chief Development Officer sale 20,225 $39.99 $808,844 4 on EDGAR
Apr 17, 2026 Third Rock Ventures V, L.P. 10% owner sale 426,005 $40.32 $17,175,244 4 on EDGAR
Apr 10, 2026 Yeleswaram Krishnaswamy Chief Development Officer sale 500 $34.98 $17,490 4 on EDGAR
Apr 8, 2026 Yeleswaram Krishnaswamy Chief Development Officer sale 360 $34.90 $12,564 4 on EDGAR
Mar 30, 2026 Gault Cheryl Chief Operating Officer sale 7,161 $28.04 $200,795 4 on EDGAR
Mar 25, 2026 Yeleswaram Krishnaswamy Chief Development Officer sale 10,115 $29.99 $303,355 4 on EDGAR
Mar 5, 2026 Gault Cheryl Chief Operating Officer sale 2,014 $28.93 $58,265 4 on EDGAR
Feb 18, 2026 Ceesay Abraham Chief Executive Officer sale 3,552 $29.05 $103,191 4 on EDGAR
Feb 17, 2026 Bredt David Chief Scientific Officer sale 900 $28.02 $25,219 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query RAPP context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access